Thyroid hormone resistance

Postgraduate Medical Journal

Volumn 84, Issue 995, 2008, Pages 473-477

  Agrawal, N K ^a,b   Goyal, R ^a   Rastogi, A ^a   Naik, D ^a   Singh, S K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b A 5 Krishna Bag Apartments ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DEXTROTHYROXINE; LEVOTHYROXINE; LIOTHYRONINE; OCTREOTIDE; THYROTROPIN; TIRATRICOL;

CELL MEMBRANE TRANSPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; FREE LIOTHYRONINE INDEX; GENE MUTATION; GOITER; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOTHYROIDISM; REVIEW; SINGLE DRUG DOSE; THYROID HORMONE RESISTANCE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; HUMANS; SYNDROME; THYROID DISEASES; THYROID HORMONES;

EID: 55349144167     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2008.069740     Document Type: Review

References (35)

1. Refetoff S, De Wind LT. De Groot LJ. Familial syndrome combining deaf-mutism, stippled epiphyses, goitre and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967;27:279-94.
2. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance of thyroid hormone. Endocr Rev 1993;14:348-99.
3. Refetoff S. Resistance to thyroid hormone. In: Braverman LE, Utiger RE, eds. Werner and Ingbar's The thyroid: a fundamental and clinical text, 9th ed. Philadelphia: Lippincott, Williams and Wilkins, 2005:1109-29.
4. Beck-Peccoz P, Chatterjee VKK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994;4:225.
5. Kaplan MM, Swartz SL, Larson PR. Partial peripheral resistance thyroid hormone. Am J Med 1981;70:1115.
6. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metabol 2007;21:277- 305.
7. Usala SJ, Bale AE, Gesundheit N, et al. Tight linkage between thyroid hormone resistance and the human c-erbAβ gene. Mol Endocrinol 1988;2:1217-20.
8. Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem 2006;43(Pt 6):431-40.
9. Adams M, Matthews C, Collingwood TN, et al. Genetic analysis of twenty-nine kindreds with generalized and pituitary resistance to thyroid hormone. J Clin Invest 1994;94:506-15.
10. Mamanasiri S, Yesil S, Dumitrescu AM, et al. Mosaicism of a thyroid hormone receptor gene mutation in resistance to thyroid hormone. J Clin Endocrinol Metab 2006;91:3471-7.
11. Weiss RE, Hayashi Y, Nagaya T, et al. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor α or β genes may be due to a defective cofactor. J Clin Endocrinol Metab 1996;81:4196-203.
12. Sadow P, Reutratkul S, Weiss RE, et al. Resistance to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes. Curr Opin Endocrinol Diabetes 2000;7:253-9.
13. Dumitrescu AM, Liao Xiao-Hui, Abdullah MSY, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005;37:1247-52.
14. Dumitrescu AM, Liao XH, Best TB, et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Human Genet 2004;74:168-75.
15. Friesema EC, Grueters A, Biebermann H, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004;364:1435-7.
16. Weiss RE, Xu J, Ning G, et al. Mice deficient in the steroid receptor coactivator I (SRC-1) are resistant to thyroid hormone. EMBO J 1999;18:1900-4.
17. Collingwood TN, Adams M, Tone Y, et al. Spectrum of transcriptional dimerization and dominant negative properties of twenty different mutant thyroid β receptors in thyroid hormone resistance syndrome. Mol Endocrinol 1994;8:1262-77.
18. Ono S, Schwartz Id, Mueller OT, et al. Homozygosity for a dominant negative thyroid hormone. J Clin Endocrinol Metab 1991;73:990-4.
19. 3 receptors and transcriptional corepressors. Mol Endocrinol 1997;11:470-80.
20. Brucker DF, Skarulis MC, Grace MB, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. Ann Intern Med 1995;123:572-83.
21. Persani L, Asteria C, Tonacchera M, et al. Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 1974;78:1034-9.
22. Hauser P, Zametkin AJ, Martinez P, et al Attention deficit-hyperactivity disorder in people with generalized resistance of thyroid hormone. N Engl J Med 1993;328:997-1001.
23. Mixson AJ, Parrilla R, Ransom SC, et al. Correlation of language abnormalities with localization of mutations in the β-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab 1992;75:1039-15.
24. Brucker-Davis F, Skarulis MC, Pikus A, et al. Prevalence and mechanism of hearing loss in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 1996;81:2768-72.
25. Chatterjee VKK, Beck-Peccoz P. The variable clinical phenotype in thyroid hormone resistance syndrome. Ballieres Clin Endocrinol Metab 1994;8:267-83.
26. Beck-Peccoz P, Piscitelli G, Gattaneo MG, et al. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983;6:217-23.
27. Radetti G, Persani L, Molinaro G, et al. Clinical and hormonal outcome after two years of TRIAC treatment in a child with thyroid hormone resistance. Thyroid 1997;7:775-8.
28. Ueda S, Takamatsu J, Fukata S, et al. Differences in response of thyrotropin to 3,5,3′-triiodothyronine and 3,5,3′-triiodothyroacetic acid in patients with resistance to thyroid hormone. Thyroid 1996;6:563-70.
29. Hamon P, Bovier-LaPierre M, Robert M, et al. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in 15-month-old boy: efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 1988;67:1089-93.
30. Dorey F, Stauch G, Gayno JP. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D-thyroxine: a study in 3 patients. Clin Endocrinol 1990;32:221-8.
31. Dulgeroff AJ, Geffner ME, Koyal SN, et al. Bromocriptine and TRIAC therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1992;75:1071-5.
32. Beck-Peccoz P, Mariotti S, Guillausseau PJ, et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab 1989;68:208-14.
33. Anselmo J, Refetoff S. Regression of large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine. Thyroid 2004;14:71-4.
34. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone - primum non nocere. J Clin Endocrinol Metab 1999;84:401-4.
35. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knock-out and knock-in mutant mice. Trends Endocrinol Metab 2003;14:85-90.